Department of Urology, Kidney Transplantation and Andrology, Toulouse University Hospital, Toulouse, France.
Department of Urology, Kidney Transplantation and Andrology, Toulouse University Hospital, Toulouse, France.
Eur Urol Focus. 2024 Jul;10(4):551-563. doi: 10.1016/j.euf.2023.11.003. Epub 2023 Nov 22.
The impact of recipient obesity on kidney transplantation (KT) outcomes remains unclear.
The aim of this study was to perform a systematic review and meta-analysis to appraise all available evidence on the outcomes of KT in obese patients (body mass index [BMI] ≥30 kg/m) versus nonobese patients (BMI <30 kg/m).
A systematic review and meta-analysis was performed. Search was conducted in the MEDLINE OvidSP, Web of Science, Google Scholar, Embase, and Cochrane databases to identify all studies reporting the outcomes of KT in obese versus nonobese recipients.
Fifty-two articles met the inclusion criteria. Delayed graft function and surgical complications were significantly higher in obese recipients (delayed graft function: relative risk [RR]: 1.44, 95% confidence interval [CI]: 1.32-1.57, p < 0.01; surgical complications: RR: 1.74, 95% CI: 1.36-2.22, p < 0.0001). Five-year patient survival (RR: 0.96, 95% CI: 0.92-1.00, p = 0.01), 10-yr patient survival (RR: 0.90, 95% CI: 0.84-0.97, p = 0.006), and 10-yr graft survival (RR: 0.87, 95% CI: 0.79-0.96, p = 0.01) were significantly inferior in the obese group.
KT in obese recipients was associated with lower patient and graft survival, and higher delayed graft function, acute rejection, and medical and surgical complications than nonobese recipients. In the current situation of organ shortage and increasing prevalence of obesity, ways to optimize KT in this setting should be investigated.
Compared with nonobese population, kidney transplantation in obese recipients has inferior patient and graft survival, and higher medical and surgical complications.
受者肥胖对肾移植(KT)结局的影响尚不清楚。
本研究旨在进行系统评价和荟萃分析,评估所有关于肥胖患者(BMI≥30kg/m)与非肥胖患者(BMI<30kg/m)接受 KT 结局的现有证据。
进行了系统评价和荟萃分析。在 MEDLINE OvidSP、Web of Science、Google Scholar、Embase 和 Cochrane 数据库中进行检索,以确定所有报告肥胖与非肥胖受者接受 KT 结局的研究。
52 篇文章符合纳入标准。肥胖受者的延迟移植物功能和手术并发症发生率显著较高(延迟移植物功能:相对风险 [RR]:1.44,95%置信区间 [CI]:1.32-1.57,p<0.01;手术并发症:RR:1.74,95%CI:1.36-2.22,p<0.0001)。5 年患者生存率(RR:0.96,95%CI:0.92-1.00,p=0.01)、10 年患者生存率(RR:0.90,95%CI:0.84-0.97,p=0.006)和 10 年移植物生存率(RR:0.87,95%CI:0.79-0.96,p=0.01)在肥胖组显著较低。
与非肥胖受者相比,肥胖受者接受 KT 后患者和移植物生存率较低,延迟移植物功能、急性排斥反应以及医疗和手术并发症发生率较高。在目前器官短缺和肥胖流行率增加的情况下,应研究优化该人群中 KT 的方法。
与非肥胖人群相比,肥胖患者接受肾移植后患者和移植物存活率较低,且医疗和手术并发症发生率较高。